Attitudes of intravenous drug users in London towards the provision of drug consumption rooms

References

• Broe, T. (2016). Making the case for drug consumption rooms. The Pharmaceutical Journal, 296, 7889. doi: 10.1211/PJ.2016.20201185
   Google Scholar
• Crofts, N., Louie, R., Rosenthal, D., & Jolley, D. (1996). The first hit: Circumstances surrounding initiation into injecting. Addiction, 91, 1187–1196. doi: 10.1046/j.1360-0443.1996.918118710.x
   PubMed Web of Science ®Google Scholar
• Cusick, L., & Kimber, J. (2007). Public perceptions of public drug use in four UK urban sites. International Journal of Drug Policy, 18, 10–17. doi: 10.1016/j.drugpo.2006.12.017
   PubMed Web of Science ®Google Scholar
• DeBeck, K., Kerr, T., Lai, C., Buxton, J., Montaner, J., & Wood, E. (2012). The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. American Journal of Drug and Alcohol Abuse, 38, 55–62. doi: 10.3109/00952990.2011.600389
   PubMed Web of Science ®Google Scholar
• Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D., & Trautmann, F. (2000). Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review, 19, 337–346. doi:10.1080/713659379
   Web of Science ®Google Scholar
• EMCDDA. (2012). Annual report: The state of the drugs problem in Europe. Lisbon: European Monitoring Centre for Drugs and Drug and Addiction
   Google Scholar
• Fisher, B., & Allard, C.A. (2007). Feasibility study on ‘supervised drug consumption’ options in the City of Victoria. Centre for Addictions Research of British Columbia (CARBC), University of Victoria
   Google Scholar
• Fry, C.L. (2002). Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. International Journal of Drug Policy, 13, 471–476. doi: 10.1016/S0955-3959(02)00076-2
   Google Scholar
• Galai, N., Safaeian, M., Vlahov, D., Bolotin, A., & Celentano, D.D. (2003). Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1988-2000: Description and determinants. American Journal of Epidemiology, 158, 695–704. doi: 10.1093/aje/kwg209
   PubMed Web of Science ®Google Scholar
• Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003). The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction, 98, 291–303. doi: 10.1046/j.1360-0443.2003.00296.x
   PubMed Web of Science ®Google Scholar
• Green, T.C., Hankins, C.A., Palmer, D., Boivin, J.-F., & Platt, R. (2004). My place, your place, or a safer place. The intention among Montréal injecting drug users to use supervised injecting facilities. Canadian Journal of Public Health, 95, 110–114. Retrieved from http://www.jstor.org/stable/41994109
   PubMed Web of Science ®Google Scholar
• Hedrich, D. (2004). European report on drug consumption rooms. Lisbon: European Monitoring Centre for Drugs and Drug Addiction
   Google Scholar
• Hedrich, D., Kerr, T., & Dubois-Arber, F. (2010). Drug consumption facilities in Europe and beyond. In Rhodes, T., & Hedrich, D. (Eds.), Harm reduction: Evidence, impact and challenges EMCDDA monographs 10 (pp. 306–331). Lisbon: EMCDDA
   Google Scholar
• Hser, Y.I., Hoffman, V., Grella, C.E., & Anglin, M.D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503–508. doi: 10.1001/archpsyc.58.5.503
   PubMed Web of Science ®Google Scholar
• Hunt, N., Lloyd, C., Kimber, J., & Tompkins, C. (2007). Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. International Journal of Drug Policy, 18, 62–65. doi: 10.1016/j.drugpo.2006.11.018
   PubMed Web of Science ®Google Scholar
• Hunt, N. (2006). Independent working group on drug consumption rooms paper A. Indicators of the need for drug consumption rooms in the UK. York: Joseph Rowntree Foundation
   Google Scholar
• IWG. (2006). The report of the Independent Working Group on drug consumption rooms. York: Joseph Rowntree Foundation
   Google Scholar
• Karimi, M., Ghaheri, H., Assari, S., Ahmadi, K., Moghani, L., Lankarani, R.M., … Jafari, F. (2014). Drug injection to sites other than arm: A study of Iranian heroin injectors. Frontiers in Psychiatry, 5, 1–5. doi: 10.3389/fpsyt.2014.00023
   PubMed Web of Science ®Google Scholar
• Kral, A.H., Wenger, L., Carpenter, L., Wood, E., Kerr, T., & Bourgois, P. (2010). Acceptability of a safer injection facility among injection drug users in San Francisco. Drug and Alcohol Dependence, 110, 160–163. doi: 10.1016/j.drugalcdep.2010.02.009
   PubMed Web of Science ®Google Scholar
• Kermode, M., Longleng, V., Singh, B.C., Hocking, J., Langkham, B., & Crofts, N. (2007). My first time: Initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduction Journal, 4, 19. doi: 10.1186/1477-7517-4-19
   PubMedGoogle Scholar
• Kerr, T., Wood, E., Small, D., Palepu, A., & Tyndall, M.W. (2003). Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Canadian Medical Association Journal, 169, 759–763
   PubMed Web of Science ®Google Scholar
• Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366, 316–318. doi: 10.1016/S0140-6736(05)66475-6
   PubMed Web of Science ®Google Scholar
• Kerr, T., Stoltz, J., Tyndall, M., Li, K., Zhang, R., Montaner, J., & Wood, E. (2006). Impact of a medically supervised safer injection facility on community drug use patterns: A before and after study. British Medical Journal, 332, 220–222. doi: 10.1136/bmj.332.7535.220
   PubMed Web of Science ®Google Scholar
• KPMG. (2010). Further evaluation of the medically supervised injecting centre during its extended trial period (2007-2011). Prepared for NSW Health by KPMG, September 2010
   Google Scholar
• Langendam, M.W., van Haastrecht, H.J., van Ameijden, E.J. (1999). The validity of drug users' self-reports in a non-treatment setting: Prevalence and predictors of incorrect reporting methadone treatment modalities. International Journal of Epidemiology, 28, 514–520. doi: 10.1093/ije/28.3.514
   PubMed Web of Science ®Google Scholar
• Latkin, C., Mandell, W., Vlahov, D., Oziemkowska, M., Knowlton, A., & Celentano, D. (1994). My place, your place, and no place: Behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. American Journal of Community Psychology, 22, 415–430. doi: 10.1007/BF02506873
   PubMed Web of Science ®Google Scholar
• Lloyd, C., & Hunt, N. (2007). Drug consumption rooms: An overdue extension to harm reduction policy in the UK? International Journal of Drug Policy, 18, 5–9. doi: 10.1016/j.drugpo.2006.12.010
   PubMed Web of Science ®Google Scholar
• Maliphant, J., & Scott, J. (2005). Use of the femoral vein (‘groin injecting’) by a sample of needle exchange clients in Bristol, UK. Harm Reduction Journal, 2, 6. doi: 10.1186/1477-7517-2-6
   PubMedGoogle Scholar
• McLellan, A.T., Lewis, D.C., O’brien, C.P., & Kleber, H.D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance and outcomes evaluation. JAMA, 284, 1689–1695. doi: 10.1001/jama.284.13.1689
   PubMed Web of Science ®Google Scholar
• MSIC Evaluation Committee. (2003). Final report on the evaluation of the Sydney Medically Supervised Injecting Centre. Sydney: Authors
   Google Scholar
• Petrar, S., Kerr, T., Tyndall, M.W., Zhang, R., Montaner, J.S.G., & Wood, E. (2007). Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility. Addictive Behaviours, 32, 1088–1093. doi: 10.1016/j.addbeh.2006.07.013
   PubMed Web of Science ®Google Scholar
• Pinkerton, S.D. (2010). Is Vancouver Canada's supervised injection facility cost-saving? Addiction, 105, 1429–1436. doi: 10.1111/j.1360-0443.2010.02977.x
   PubMed Web of Science ®Google Scholar
• Potier, C., Laprevote, V., Dubois-Arber, Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic review. Drug and Alcohol Dependence, 45, 48–68. doi: 10.1016/j.drugalcdep.2014.10.012
   Google Scholar
• Rhodes, T., Stoneman, A., Hopea, V., Hunt, N., Martin, A., & Judd, A. (2006). Groin injecting in the context of crack cocaine and homelessness: From ‘risk boundary’ to ‘acceptable risk’? International Journal of Drug Policy, 17, 164–170. doi: 10.1016/j.drugpo.2006.02.011
   Web of Science ®Google Scholar
• Termorshuizen, F., Krol, A., Prins, M., Geskus, R., van den Brink, W., & van Ameijden, E.J.C. (2005). Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users. Drug and Alcohol Dependence, 79, 231–240. doi: 10.1016/j.drugalcdep.2005.01.013
   PubMed Web of Science ®Google Scholar
• Van Beek, I., & Gilmour, S. (2000). Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Australian and New Zealand Journal of Public Health, 24, 540–542. doi: 10.1111/j.1467-842X.2000.tb00507.x
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Spittal, P.M., Li, K., Small, W., Tyndall, M.W., … Schechter, M.T. (2003). The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes, 32, 2–8. doi: 10.1097/00126334-200301010-00002
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Small, W., Li, K., Marsh, D.C., Montaner, J.S.G., & Tyndall, M.W. (2004). Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal, 171, 731–734. doi: 10.1503/cmaj.1040774
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M.W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J.S.G., & Kerr, T. (2005). Do supervised injecting facilities attract higher-risk injection drug users? American Journal of Preventive Medicine, 29, 126–130. doi: 10.1016/j.amepre.2005.04.011
   PubMed Web of Science ®Google Scholar
• Woods, S. (2014). Organisational overview of dug consumption rooms in Europe. European Harm Reduction Network. Regenboog Groep: Amsterdam. Retrieved from: www.eurohrn.eu/index.php/drug-consumption-rooms
   Google Scholar
• Zadjow, G. (2006). The narrative of evaluations: Medically supervised injecting centers. Contemporary Drug Problems, 33, 399–426
   Google Scholar